Clinical Overview of Biotin (Vitamin B7)
Biotin acts as an essential coenzyme for five carboxylases in humans involved in gluconeogenesis, fatty acid synthesis, and amino acid metabolism. True nutritional deficiency is rare. Deficiency predominantly arises from inborn errors of metabolism (biotinidase deficiency), prolonged TPN lacking vitamins, raw egg white ingestion (avidin), or chronic anticonvulsants.
True biotin deficiency — when does it occur?
True biotin deficiency is uncommon but occurs in: prolonged consumption of raw egg whites (avidin in raw egg whites binds and blocks biotin absorption), prolonged parenteral nutrition without biotin supplementation, biotinidase deficiency (genetic), prolonged anticonvulsant therapy (valproate and carbamazepine impair biotin metabolism), and alcoholism with malabsorption. Clinical features include: seborrhoeic dermatitis, alopecia, conjunctivitis, ataxia, hypotonia, and in severe cases seizures and developmental regression.
Biotinidase Deficiency Protocol
Biotinidase deficiency is an autosomal recessive disorder preventing the recycling of free biotin from biocytin. Profound deficiency (<10% activity) requires immediate oral free biotin at 5 to 20 mg/day lifelong to avoid irreversible optic atrophy, neurosensory deafness, and seizures. Partial deficiency (10–30% activity) is treated with lower doses (1–5 mg/day) and may have a milder course. Detection is via newborn screening (now available in several Indian states); confirmatory testing includes serum biotinidase enzyme activity assay followed by genetic testing (BTD gene). Key Indian referral centres: AIIMS Delhi Biochemical Genetics, CMC Vellore, NIMHANS.
High-dose biotin for hair and nails — separating evidence from marketing
Biotin is extensively marketed in India for hair fall and brittle nails at doses of 5000–10,000 mcg (5–10 mg/day). The evidence base is limited to case reports and small uncontrolled studies in patients with documented biotin deficiency — most of whom had underlying causes like biotinidase deficiency or raw egg consumption. There is no robust evidence that high-dose biotin supplementation benefits hair growth or nail quality in individuals with normal biotin levels. Importantly, high-dose biotin causes false laboratory results in many commonly ordered tests — a risk that is widely underappreciated in Indian clinical practice.
| Indication | Dose | Duration | Evidence |
|---|---|---|---|
| Biotinidase deficiency — profound | 5–20 mg/day (free biotin) | Lifelong | Strong (IEM guidelines) |
| Biotinidase deficiency — partial | 1–5 mg/day | Lifelong | Strong |
| Acquired biotin deficiency | 5–20 mg/day | Until resolved + treat cause | Moderate |
| Anticonvulsant-related depletion | 5–10 mg/day | Throughout therapy | Moderate |
| Biotin-responsive basal ganglia disease | 5–10 mg/kg/day | Lifelong | Strong (case series) |
| Hair loss / nail supplementation (no deficiency) | No established dose | — | Insufficient evidence |
| High-dose MS (investigational) | 100–300 mg/day | Ongoing trials | Investigational only |